Quantitative MRI Assessment of Myotoxin‐Induced Skeletal Muscle Damage of mdx Mice Authors: Ravneet Vohra, Joshua Park, Feng Zhang, Jeffrey S. Chamberlain, Donghoon Lee Published: 2026 ABSTRACT ABSTRACTIntroduction/AimsAlthough magnetic resonance imaging (MRI) has been extensively applied in dystrophic muscle, longitudinal characterization of multiple quantitative MRI parameters during degeneration and regeneration remains limited. This study aimed to longitudinally characterize changes in quantitative MRI parameters in control and dystrophic mouse muscles following myotoxin‐induced myonecrosis using multi‐parametric MRI (mpMRI).MethodsmpMRI was performed at 14 Tesla in mdx 4cv mice (n = 10) and control (ctrl) mice (n = 5) following intramuscular BaCl2 injection. Quantitative maps of T1, T2, magnetization transfer ratio (MTR), and diffusion metrics were obtained from myotoxin‐ and saline‐injected hind‐limb muscles at multiple time points.ResultsMean T1 values decreased, reaching minima at day 5 in ctrl (3.05 ± 0.67 s) and day 3 in mdx 4cv (2.60 ± 0.28 s) muscles. Mean T2 values increased and peaked at day 3 in both ctrl (34.83 ± 4.73 ms) and mdx 4cv (33.53 ± 2.98 ms) muscles. MTR values decreased, reaching lowest levels at day 5 post‐injection in both ctrl (69.12% ± 6.23%) and mdx 4cv (69.20% ± 5.83%) muscles. T1, T2, and MTR returned to near‐baseline values by day 21 day. Diffusion metrics demonstrated early increases in mean and radial diffusivity with a concomitant decrease in fractional anisotropy, followed by recovery between days 5 and 7.DiscussionmpMRI revealed distinct, time‐dependent changes following myotoxin injury, demonstrating the added value of mpMRI as a noninvasive approach for sensitively characterizing the temporal evolution of quantitative MRI parameters following myotoxin‐induced muscle injury in both control and dystrophic mice. Introduction/Aims Pathogenic variants in the dystrophin gene cause Duchenne muscular dystrophy (DMD) [1]. The time course for skeletal muscle regeneration often depends on the extent of injury, ranging from one to 2 weeks in pre‐clinical models [2, 3]. Acute injury models have been used to investigate the degenerative and regenerative processes through histological techniques [4, 5, 6]. Although these techniques provide indispensable information, they are invasive and require euthanizing the animals. In contrast, magnetic resonance imaging (MRI) can evaluate muscle injury in live animals. While multi‐parametric MRI (mpMRI) is sensitive to muscle tissue alterations and enables noninvasive longitudinal monitoring, its ability to identify specific underlying pathological processes remains limited and is an ongoing focus of research. T1 and T2‐weighted MRI techniques have been used to characterize affected muscles in pre‐clinical and clinical models of DMD [4, 7, 8]. These relaxation time constants in biological tissues provide a method to examine the distribution and biophysical properties of water in vivo [9, 10, 11]. Magnetization transfer (MT) imaging assesses macromolecular environments and detects structural abnormalities in diseased skeletal muscles [6, 12]. Diffusion‐weighted imaging (DWI) measures water diffusion in tissues and uses parameters like mean diffusivity (MD), radial diffusivity (RD), and fractional anisotropy (FA) in models of muscle injury [13, 14]. Multi‐parametric MRI (mpMRI) integrates complementary quantitative measures, offering a more comprehensive assessment of muscle injury and regeneration than any single MRI parameter alone [15, 16]. The purpose of this study was to characterize the temporal evolution of quantitative MRI parameters in hind limb muscles following myotoxin‐induced damage in dystrophic and control mice. Specifically, we aimed to compare time‐dependent changes and recovery patterns among individual quantitative MRI parameters following myotoxin‐induced muscle injury. Methods All animal experiments were conducted in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Experimental Animals, and the protocols were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC, protocol number 4210‐01) of the University of Washington. Animals Details of the animal methods are provided in the Supporting Information. MR Imaging Multi‐parametric 1H MRI was performed for mdx 4cv and control mice using a Bruker 14 T (T) Advance MR spectrometer (Bruker Corp., Billerica, MA). Both mdx 4cv mice and ctrl mice were imaged at day 0, 2, 3, 5, 7, 14 and 21 post intramuscular injection of myotoxin (supplementary Figure 1). The lower hindlimbs of the mouse were inserted and centered in a 2.5‐cm internal diameter birdcage 1H transceiver coil (600 MHz) for the imaging. The high‐resolution MRI images were acquired as described previously [16]. Imaging Analysis Mean values of T1, T2, magnetization transfer ratio (MTR), radial diffusivity (RD), and mean diffusivity (MD) were measured on tibialis anterior (TA), gastrocnemius (GA), and soleus (SO) muscles and compared between ctrl and mdx mice. Imaging analysis was performed using ImageJ (http://rsbweb.nih.gov/ij) using methods previously described [16]. Statistical Analysis All statistical analyses were conducted using Graph Pad Prism 8.0 software (GraphPad Software, Boston, MA, USA). Values of myotoxin‐ and saline‐injected TA muscles were compared at different time points in mdx 4cv and ctrl mice using two‐way ANOVA followed by Bonferroni multiple comparison test. Three sets of comparisons were evaluated: (1) saline‐ versus myotoxin‐injected muscles; (2) temporal differences among myotoxin‐injected muscles; (3) differences between ctrl and mdx mice for myotoxin‐injected muscles (‡). Data are presented as the mean ± standard deviation, and a statistical significance was defined as p < 0.05. Results T1 Measurements in Injured Muscles Post myotoxin injection, both ctrl and mdx 4cv muscles demonstrated significant T1 changes compared to saline injected muscles over 3 weeks. T1 differed significantly between ctrl saline and myotoxin injected TA at days 2, 3, and 5 (Table 1 and supplementary Figure 2). Significant differences were noted in mdx 4cv saline and myotoxin injected TA at days 2, 3, and 5. Finally, T1 was significantly different between ctrl and mdx 4cv at day 5 post myotoxin injection (p < 0.001) (Table 1). TABLE 1T1 (s), T2 (ms), MTR (%), FA (au), MD (10−3×mm2/s) and RD (10−3×mm2/s) values from ctrl and mdx 4cv mice saline and myotoxin injected muscles.C57BL/6 (Ctrl)Day 0Day 2Day 3Day 5Day 7Day 14Day 21SalineMyotoxinSalineMyotoxinSalineMyotoxinSalineMyotoxinSalineMyotoxinSalineMyotoxinSalineMyotoxinT1 (s)3.15 ± 0.632.98 ± 1.233.06 ± 0.88 * 2.72 ± 0.38 3.12 ± 0.92 *** # 2.60 ± 0.28 3.05 ± 0.67 *** #### 2.41 ± 1.09 3.18 ± 0.49 *** 2.63 ± 1.81 3.15 ± 0.433.16 ± 4.433.12 ± 1.403.10 ± 7.31T2 (ms) 18.94 ± 0.98 22.42 ± 2.8718.34 ± 0.86 **** #### 33.59 ± 2.69 18.07 ± 0.59 **** #### 34.83 ± 4.73 17.92 ± 0.32 **** #### 30.82 ± 4.85 17.82 ± 0.40 **** 25.74 ± 3.70 17.94 ± 0.4419.94 ± 0.8717.78 ± 0.1918.63 ± 0.24MTR (%) 82.31 ± 0.97 81.43 ± 1.2782.01 ± 0.73 **** 76.50 ± 1.81 82.70 ± 0.52 **** ### 73.39 ± 3.60 82.84 ± 0.17 **** #### 69.12 ± 6.23 82.96 ± 0.87 **** #### 72.38 ± 4.49 81.65 ± 1.4077.46 ± 2.4883.92 ± 0.7082.59 ± 0.99FA (au) 0.32 ± 0.04 * 0.51 ± 0.11 0.41 ± 0.14 ## 0.30 ± 0.06 0.44 ± 0.14 # 0.35 ± 0.13 0.45 ± 0.060.47 ± 0.050.41 ± 0.070.46 ± 0.100.40 ± 0.040.40 ± 0.070.42 ± 0.110.46 ± 0.09MD (10−3 × mm2/s)1.74 ± 0.12 1.48 ± 0.08 1.57 ± 0.131.73 ± 0.161.39 ± 0.111.49 ± 0.121.52 ± 0.10 * #### 1.25 ± 0.14 1.51 ± 0.12 * #### 1.26 ± 0.12 1.50 ± 0.05 #### 1.40 ± 0.08 1.61 ± 0.231.48 ± 0.08RD (10−3 × mm2/s)1.41 ± 0.13 ** 1.07 ± 0.16 1.20 ± 0.211.45 ± 0.171.05 ± 0.201.21 ± 0.181.13 ± 0.13 #### 0.92 ± 0.07 1.15 ± 0.15 #### 0.92 ± 0.14 1.17 ± 0.06 #### 1.08 ± 0.09 1.21 ± 0.111.11 ± 0.13mdx4cv (mdx)Day 0Day 2Day 3Day 5Day 7Day 14Day 21SalineMyotoxinSalineMyotoxinSalineMyotoxinSalineMyotoxinSalineMyotoxinSalineMyotoxinSalineMyotoxinT1 (s) 3.04 ± 0.20 3.05 ± 0.182.92 ± 0.21 * ## 2.66 ± 0.24 2.98 ± 0.19 *** #### 2.55 ± 0.17 3.08 ± 0.18 * ‡ 2.82 ± 0.25 3.05 ± 0.312.91 ± 0.383.04 ± 0.113.02 ± 0.113.10 ± 0.123.07 ± 0.12T2 (ms) 22.72 ± 4.34 24.12 ± 4.1921.73 ± 4.14 **** #### 33.23 ± 2.84 23.54 ± 4.44 **** #### 33.53 ± 2.98 21.00 ± 2.30 **** ‡ 27.15 ± 2.90 20.42 ± 1.37 ** 24.03 ± 1.28 19.41 ± 0.7519.54 ± 1.0519.85 ± 0.7219.50 ± 0.55MTR (%) 80.65 ± 1.75 79.71 ± 2.2980.15 ± 2.02 ## 75.77 ± 2.32 80.17 ± 2.68 *** #### 72.19 ± 2.67 76.35 ± 5.75 ** #### 69.20 ± 5.83 80.47 ± 1.6477.03 ± 3.4881.07 ± 0.5180.47 ± 1.7081.76 ± 1.3982.02 ± 1.33FA (au) 0.54 ± 0.08 0.47 ± 0.120.48 ± 0.08 ### 0.39 ± 0.08 0.45 ± 0.11 ### 0.44 ± 0.13 0.57 ± 0.10 ‡ 0.70 ± 0.12 0.46 ± 0.10 # 0.53 ± 0.13 0.55 ± 0.09 # 0.54 ± 0.16 0.50 ± 0.10 ### 0.47 ± 0.09 MD (10−3 × mm2/s)1.62 ± 0.161.55 ± 0.161.49 ± 0.131.60 ± 0.071.39 ± 0.111.42 ± 0.121.68 ± 0.13 *** ‡ 1.48 ± 0.17 1.42 ± 0.12 ** #### 1.22 ± 0.09 1.31 ± 0.161.32 ± 0.181.38 ± 0.211.32 ± 0.16RD (10−3 × mm2/s)1.15 ± 0.161.18 ± 0.151.07 ± 0.161.28 ± 0.141.06 ± 0.081.04 ± 0.171.14 ± 0.10 ## 0.84 ± 0.06 1.05 ± 0.12 ### 0.88 ± 0.12 0.95 ± 0.171.00 ± 0.171.04 ± 0.181.01 ± 0.12 Note: * Represents significant difference between saline‐injected and myotoxin‐injected muscles. # Represents significant difference between myotoxin‐injected muscles at different time points. ‡ Represents significant difference between myotoxin injected ctrl and mdx 4cv muscles. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001, this also applies to the other symbols. T1 (s), T2 (ms), MTR (%), FA (au), MD (10−3×mm2/s) and RD (10−3×mm2/s) values from ctrl and mdx 4cv mice saline and myotoxin injected muscles. * 2.72 ± 0.38 *** # 2.60 ± 0.28 *** #### 2.41 ± 1.09 *** 2.63 ± 1.81 18.94 ± 0.98 **** #### 33.59 ± 2.69 **** #### 34.83 ± 4.73 **** #### 30.82 ± 4.85 **** 25.74 ± 3.70 82.31 ± 0.97 **** 76.50 ± 1.81 **** ### 73.39 ± 3.60 **** #### 69.12 ± 6.23 **** #### 72.38 ± 4.49 0.32 ± 0.04 * 0.51 ± 0.11 ## 0.30 ± 0.06 # 0.35 ± 0.13 1.48 ± 0.08 * #### 1.25 ± 0.14 * #### 1.26 ± 0.12 #### 1.40 ± 0.08 ** 1.07 ± 0.16 #### 0.92 ± 0.07 #### 0.92 ± 0.14 #### 1.08 ± 0.09 3.04 ± 0.20 * ## 2.66 ± 0.24 *** #### 2.55 ± 0.17 * ‡ 2.82 ± 0.25 22.72 ± 4.34 **** #### 33.23 ± 2.84 **** #### 33.53 ± 2.98 **** ‡ 27.15 ± 2.90 ** 24.03 ± 1.28 80.65 ± 1.75 ## 75.77 ± 2.32 *** #### 72.19 ± 2.67 ** #### 69.20 ± 5.83 0.54 ± 0.08 ### 0.39 ± 0.08 ### 0.44 ± 0.13 ‡ 0.70 ± 0.12 # 0.53 ± 0.13 # 0.54 ± 0.16 ### 0.47 ± 0.09 *** ‡ 1.48 ± 0.17 ** #### 1.22 ± 0.09 ## 0.84 ± 0.06 ### 0.88 ± 0.12 Note: * Represents significant difference between saline‐injected and myotoxin‐injected muscles. # Represents significant difference between myotoxin‐injected muscles at different time points. ‡ Represents significant difference between myotoxin injected ctrl and mdx 4cv muscles. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001, this also applies to the other symbols. T2 Measurements in Injured Muscles Temporal changes in T2 maps from ctrl and mdx 4cv mice demonstrated changes in TA muscle post saline and myotoxin injection (Figure 1). Post myotoxin injection, both ctrl and mdx 4cv muscles responded similarly. In ctrl muscles, T2 values peaked at day 3 post myotoxin injection and returned to values comparable to day 0 by day 21. Similarly, mdx 4cv T2 values peaked at day 3, decreased sharply at day 5, and approached baseline values by day 21 (Table 1). Dynamic changes of MRI T2 during muscle damage and repair. Representative T2 colored maps acquired from hind limb muscles of ctrl (A) and mdx 4cv (B) mice. Graphs displaying average T2 values in saline and myotoxin injected ctrl (C), mdx 4cv muscles (D), and comparison between ctrl and mdx 4cv mice for myotoxin‐injected muscles (E). * represents a significant difference between saline‐injected and myotoxin‐injected muscles. # represents a significant difference between myotoxin‐injected muscles at different time points (symbols are shown in the Table 1). ‡ represents a significant difference between myotoxin‐injected ctrl and mdx 4cv muscles. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001; this also applies to the other symbols. A colorbar indicates the range of T2 mean values. The color scale reflects quantitative T2 values across leg muscles. MTR in Injured Muscles MTR maps from ctrl and mdx 4cv mice demonstrated changes in TA muscle post saline and myotoxin injection (Figure 2). In both groups, MTR values decreased after myotoxin administration, reaching their lowest levels around day 5 before gradually returning toward baseline by day 21 (Table 1). Significant differences were observed between saline‐ and myotoxin‐injected muscles at multiple time points, as well as between ctrl and mdx4cv myotoxin‐injected muscles. Dynamic changes of MRI MTR during muscle damage and repair. Representative MTR colored maps acquired from hind limb muscles of ctrl (A) and mdx 4cv (B) mice. Graphs displaying average MTR values in saline and myotoxin injected ctrl (C), mdx 4cv muscles (D), and comparison between ctrl and mdx 4cv for myotoxin‐injected muscles (E). * represents a significant difference between saline‐injected and myotoxin‐injected muscles. # represents a significant difference between myotoxin‐injected muscles at different time points (symbols are shown in the Table 1). ‡ represents a significant difference between myotoxin‐injected control and mdx 4cv muscles. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001; this also applies to the other symbols. A colorbar indicates the range of MTR mean values. The color scale reflects quantitative MTR values across leg muscles. Diffusion Measurements in Injured Muscles Myotoxin‐injected mdx 4cv muscles demonstrated higher fractional anisotropy (FA) compared to ctrl muscles at day 5 (Table 1 and supplementary Figure 3). Mean diffusivity (MD) and radial diffusivity (RD) increased early, peaking at day 2 post‐injection in both groups, and declined to their lowest values between days 5 and 7. FA decreased immediately after myotoxin injection and recovered by day 7. Discussion The multi‐parametric approach revealed distinct, time‐dependent changes post‐myotoxin injury. All quantitative MRI parameters exhibited dynamic, temporal variations, underscoring the value of longitudinal assessment for capturing the progression and recovery of muscle injury. Changes in T1 and T2 Time In the present study, we observed significant changes in T1 and T2 time constants after myotoxin injection. Our results contrast with previously published findings that show an increase in T1 with muscle injury and post‐exercise [4, 17]. The reduction in T1 observed in this study may reflect early necrosis induced by myotoxin. BaCl2 is known to cause muscle damage through Ca2 +‐mediated proteolysis, membrane disruption, and myofiber necrosis, while sparing blood vessels [18]. Our findings are consistent with previous reports demonstrating significant myofiber damage and edema within hours of myotoxin injection [6], with similar changes observed by day 2 in the present study. Furthermore, early lipid droplet accumulation after muscle injury has been reported [19], which may contribute not only to reductions in muscle T1 but also to part of the observed T2 increase. Elevated T2 in the inflamed skeletal muscles [4, 20] additionally reflects increased vascular permeability and extracellular fluid [4, 21]. Notably, T2 in dystrophic muscle recovered faster than in control, likely due to ongoing cycles of degeneration and regeneration. In dystrophic muscle, satellite cells are already activated, whereas in healthy muscles they remain quiescent until injury triggers proliferation. Changes in MTR Following tissue injury, a decrease in magnetization transfer ratio (MTR) can reflect both loss or disruption of macromolecular structure and an increase in free water content associated with inflammation and edema, which reduces the relative macromolecular proton fraction. Such reductions in MTR have been reported previously in dystrophic and myotoxin‐injured skeletal muscle [4, 6]. Moreover, our laboratory has previously demonstrated significant differences between young ctrl and mdx 4cv mice [16]. In this study, both ctrl and mdx 4cv muscles demonstrate a decrease in MTR following myotoxin injection. Furthermore, MTR shows a delayed response compared to T2 relaxation time constants. Changes in Diffusion Parameters Mean diffusivity (MD) and radial diffusivity (RD) in myotoxin‐injected muscles demonstrated time‐dependent changes. Myotoxin injection was associated with increased diffusivity and reduced fractional anisotropy (FA) over time in injured muscles [4, 22, 23]. FA dropped immediately after injection in both ctrl and mdx 4cv muscles, recovered at day 7, and later rose above baseline in mdx 4cv during early regeneration—likely due to small‐diameter fiber formation—before declining with fiber maturation. These assumptions have been supported by a previously published study [16]. We showed that combining T1, T2, MTR, and diffusion metrics reveals distinct, time‐dependent temporal profiles following myotoxin injury, highlighting the potential value of a longitudinal multiparametric MRI approach for complementary assessment of muscle tissue changes over time. A key limitation of this study is the absence of histology, though prior studies [3, 4, 20, 22, 24] show strong MRI‐histology correlations. Our findings support multi‐parametric MRI as a noninvasive tool for tracking muscle injury and recovery, with potential applications in monitoring disease progression, therapeutic response, and clinical trial design. Future work should integrate imaging with histology to better connect imaging changes to underlying tissue biology and assess how sensitively these MRI measures track muscle injury, regeneration, and treatment response over time. Conclusions We have shown that dystrophic and healthy muscles exhibit differing quantitative MRI trajectories following myotoxin‐induced injury. This work demonstrates that individual MRI parameters display distinct sensitivities and recovery trajectories that cannot be captured solely by single‐metric approaches. The current study of monitoring temporal changes in both dystrophic and healthy muscles enhances our understanding of how these processes influence various quantitative MRI measures. A critical next step in contextualizing these findings, not covered in this preliminary work, is to integrate imaging data with histological biomarkers. Author Contributions Feng Zhang: investigation, writing – review and editing, methodology. Ravneet Vohra: methodology, formal analysis, data curation, visualization, writing – review and editing, validation, writing – original draft, investigation, conceptualization. Donghoon Lee: conceptualization, investigation, funding acquisition, writing – original draft, writing – review and editing, methodology, formal analysis, project administration, data curation, supervision, resources, validation, visualization. Joshua Park: investigation, methodology, validation, writing – review and editing, project administration. Jeffrey S. Chamberlain: writing – review and editing, investigation, funding acquisition. Funding This work was supported by the National Institutes of Health, CA188654, and AR040864; Muscular Dystrophy Association, 312455. Disclosure We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Data S1: Supporting Information. Supplementary Figure 1 Graphical representation of experimental design. Supplementary Figure 2 Representative T1 colored maps acquired from hind limb muscles of ctrl (A) and mdx 4cv (B) mice. Graphs displaying average T1 values in saline and myotoxin‐injected ctrl (C), mdx 4cv muscles (D), and comparison between ctrl and mdx 4cv mice for myotoxin‐injected muscles (E). * represents a significant difference between saline‐injected and myotoxin‐injected muscles. # represents a significant difference between myotoxin‐injected muscles at different time points (symbols are shown in the Table 1). ‡ represents a significant difference between myotoxin‐injected ctrl and mdx 4cv muscles. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001, this also applies to the other symbols. A colorbar indicates the range of T1 mean values. The color scale reflects quantitative T1 values across leg muscles. Supplementary Figure 3 Graphs displaying average FA values in saline and myotoxin‐injected ctrl (A), mdx 4cv muscles (B), and comparison between ctrl and mdx 4cv mice for myotoxin‐injected muscles (C). Additional graphs displaying average MD values in saline and myotoxin‐injected ctrl (D), mdx 4cv muscles (E), and comparison between ctrl and mdx 4cv mice for myotoxin‐injected muscles (F). Finally, graphs displaying average RD values in saline and myotoxin‐injected ctrl (G), mdx 4cv muscles (H), and comparison between ctrl and mdx 4cv mice for myotoxin‐injected muscles (I). * represents a significant difference between saline‐injected and myotoxin‐injected muscles. # represents a significant difference between myotoxin‐injected muscles at different time points (symbols are shown in the Table 1). ‡ represents a significant difference between myotoxin‐injected ctrl and mdx 4cv muscles. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001, this also applies to the other symbols.